Does Pfizer's merge-and-purge cost the company R&D?
Has the drug industry simply gotten too big for its britches? We wondered when we got word of Pfizer's latest binge and purge, a drill that's doubtless giving alumni of Warner-Lambert, Parke-Davis, Upjohn, Searle and Pharmacia déjà vu.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.